{"disease":{"id":"unresectable-nasopharyngeal-carcinoma","name":"unresectable nasopharyngeal carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04921995","title":"Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Fudan University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}